XML 53 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of Income Tax Expense

A reconciliation of the income tax expense computed using the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

As of December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Federal statutory rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

State income taxes, net of federal benefit

 

 

7.0

 

 

 

13.3

 

 

 

7.4

 

Research and development tax credits

 

 

4.7

 

 

 

18.0

 

 

 

4.2

 

Nondeductible/ nontaxable permanent items

 

 

(1.6

)

 

 

(2.5

)

 

 

(1.8

)

Change in valuation allowance

 

 

(31.1

)

 

 

(50.9

)

 

 

(32.0

)

Total

 

 

0.0

%

 

 

-1.1

%

 

 

-1.2

%

Schedule of Components of Deferred Taxes

The components of the Company’s deferred taxes are as follows (in thousands):

 

 

December 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

48,954

 

 

$

3,959

 

Research and development tax credits

 

 

87,554

 

 

 

56,759

 

Accrued expenses and other

 

 

12,868

 

 

 

17,386

 

Deferred revenue

 

 

38,815

 

 

 

48,792

 

Derivative liabilities

 

 

3,771

 

 

 

2,951

 

Equity compensation

 

 

21,218

 

 

 

20,587

 

Amortization

 

 

30,508

 

 

 

30,917

 

Capitalized Research

 

 

180,954

 

 

 

137,721

 

Lease liability

 

 

44,096

 

 

 

47,179

 

Total deferred tax assets

 

 

468,738

 

 

 

366,251

 

ROU asset

 

 

(28,649

)

 

 

(30,830

)

Property and equipment

 

 

(267

)

 

 

(649

)

Other

 

 

(1,563

)

 

 

(5,415

)

Less: valuation allowance

 

 

(438,259

)

 

 

(329,357

)

Total

 

$

 

 

$